/Investor DB

Flyover Capital — 2026 Investments

4 investments dated 2026 · listed companies and verified rows first · show all

Kyrakyra.cominApr 2026

Kyra runs influencer marketing programs for global brands, activating creators across TikTok, Instagram, and YouTube and analyzing large volumes of creator video to forecast and measure campaign outcomes.

AdTechAI & Machine LearningCreator EconomyMarketing Tech

Dev Karaca(Founder)inDevran Amaratunga Karaca(CEO & Co-Founder)Nicholas Dart(COO/CTO & Co-Founder)inStewart Rawle(Chief Commercial Officer)inSteph Fadahunsi(Chief People Officer)Ed Galvin(Chief Financial Officer)in

Co-investorsGMG VenturesTorch CapitalBonnier VenturesLionTreeBonnier CapitalMercuri.vc+6 more

Paralign Healthhealthworxstudio.cominMay 2026

Healthworx Studio is a venture studio that partners with healthcare stakeholders to identify systemic problems and build and scale new healthcare companies.

Digital HealthHealthtechNew York, US

Aaron Molloy(Executive Officer, Director)in

BoardPatrick Berry(Director)inMichael Batista(Director)

Co-investorsForum VenturesGovtech VenturesSixThirty VenturesSorenson Impact FoundationSpringTime VenturesStone Mountain Ventures

Paralign Healthparalign.healthMay 2026 · $3M

Paralign enables health plans to deploy emergency services teams for preventative care delivery in underserved communities.

Digital HealthHealthtechSaaSRevere, US

Aaron

Co-investorsGovtech VenturesSixThirty VenturesStone Mountain VenturesForum VenturesSorenson Impact FoundationSpringTime Ventures

ReFiBuyrefibuy.aiin𝕏Apr 2026

ReFiBuy provides a platform for optimizing product data and visibility across AI-driven shopping environments and agents.

AI & Machine LearningE-commerceEnterprise SoftwareMarketing TechRaleigh, US

M. Scot Wingo(Executive Officer, Director)inDerek Lee Conlin(Executive Officer, Director)

BoardStefan Sterns(Director)in

Co-investorsAtento CapitalG20 VenturesIncubate USKnoll VenturesNewRoad Capital Partners, LLCVela Partners+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.